These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 6787737)

  • 1. The formation of 2,3-dihydroxy-2,3-dihydro-aflatoxin B1 by the metabolism of aflatoxin B1 by liver microsomes isolated from certain avian and mammalian species and the possible role of this metabolite in the acute toxicity of aflatoxin B1.
    Neal GE; Judah DJ; Stirpe F; Patterson DS
    Toxicol Appl Pharmacol; 1981 May; 58(3):431-7. PubMed ID: 6787737
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic basis of the species difference to aflatoxin B1 induced hepatotoxicity.
    O'Brien K; Moss E; Judah D; Neal G
    Biochem Biophys Res Commun; 1983 Jul; 114(2):813-21. PubMed ID: 6411093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The formation of 2,3-dihydro-2,3-dihydroxy aflatoxin B1 by the metabolism of aflatoxin B1 in vitro by rat liver microsomes.
    Neal GE; Colley PJ
    FEBS Lett; 1979 May; 101(2):382-6. PubMed ID: 36299
    [No Abstract]   [Full Text] [Related]  

  • 4. The in vitro metabolism of aflatoxin B1 catalyzed by hepatic microsomes isolated from control or 3-methylcholanthrene-stimulated rats and quail.
    Neal GE; Judah DJ; Green JA
    Toxicol Appl Pharmacol; 1986 Mar; 82(3):454-60. PubMed ID: 3082038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purified form of cytochrome P-450 from rainbow trout with high activity toward conversion of aflatoxin B1 to aflatoxin B1-2,3-epoxide.
    Williams DE; Buhler DR
    Cancer Res; 1983 Oct; 43(10):4752-6. PubMed ID: 6411332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidation of aflatoxins and sterigmatocystin by human liver microsomes: significance of aflatoxin Q1 as a detoxication product of aflatoxin B1.
    Raney KD; Shimada T; Kim DH; Groopman JD; Harris TM; Guengerich FP
    Chem Res Toxicol; 1992; 5(2):202-10. PubMed ID: 1643250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species susceptibility to aflatoxin B1 carcinogenesis: comparative kinetics of microsomal biotransformation.
    Ramsdell HS; Eaton DL
    Cancer Res; 1990 Feb; 50(3):615-20. PubMed ID: 2105159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced hepatotoxicity of aflatoxin B1 by pretreatment of rats with ethanol.
    Toskulkao C; Taycharpipranai S; Glinsukon T
    Res Commun Chem Pathol Pharmacol; 1982 Jun; 36(3):477-91. PubMed ID: 6812183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced nicotinamide adenine dinucleotide phosphate-dependent formation of 2,3-dihydro-2,3-dihydroxyaflatoxin B1 from aflatoxin B1 by hepatic microsomes.
    Lin JK; Kennan KA; Miller EC; Miller JA
    Cancer Res; 1978 Aug; 38(8):2424-8. PubMed ID: 27299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver microsomal metabolism of aflatoxin B 1 to a reactive derivative toxic to Salmonella typhimurium TA 1530.
    Garner RC; Miller EC; Miller JA
    Cancer Res; 1972 Oct; 32(10):2058-66. PubMed ID: 4404160
    [No Abstract]   [Full Text] [Related]  

  • 11. Some high-performance liquid-chromatographic studies of the metabolism of aflatoxins by rat liver microsomal preparations.
    Neal GE; Colley PJ
    Biochem J; 1978 Sep; 174(3):839-51. PubMed ID: 728090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in aflatoxin B1-susceptibility of rat and mouse are correlated with the capability in vitro to inactivate aflatoxin B1-epoxide.
    Degen GH; Neumann HG
    Carcinogenesis; 1981; 2(4):299-306. PubMed ID: 6791853
    [No Abstract]   [Full Text] [Related]  

  • 13. The metabolism of aflatoxin B1 by human liver.
    Moss EJ; Neal GE
    Biochem Pharmacol; 1985 Sep; 34(17):3193-7. PubMed ID: 3929787
    [No Abstract]   [Full Text] [Related]  

  • 14. 2,3-Dihydro-2,3-dihydroxy-aflatoxin B1: an acid hydrolysis product of an RNA-aflatoxin B1 adduct formed by hamster and rat liver microsomes in vitro.
    Swenson DH; Miller JA; Miller EC
    Biochem Biophys Res Commun; 1973 Aug; 53(4):1260-7. PubMed ID: 4748819
    [No Abstract]   [Full Text] [Related]  

  • 15. The formation of aflatoxins B2a and G2a and their degradation products during the in vitro detoxification of aflatoxin by livers of certain avian and mammalian species.
    Patterson DS; Roberts BA
    Food Cosmet Toxicol; 1970 Oct; 8(5):527-38. PubMed ID: 5492926
    [No Abstract]   [Full Text] [Related]  

  • 16. Some mass-spectral and n.m.r. analytical studies of a glutathione conjugate of aflatoxin B1.
    Moss EJ; Judah DJ; Przybylski M; Neal GE
    Biochem J; 1983 Jan; 210(1):227-33. PubMed ID: 6133517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mutagenicity of aflatoxin Q1 to Salmonella typhimurium TA 100 with or without rat or human liver microsomal preparations.
    Yourtee DM; Kirk-Yourtee CL
    Res Commun Chem Pathol Pharmacol; 1986 Oct; 54(1):101-13. PubMed ID: 3099349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sex difference on the in vitro and in vivo metabolism of aflatoxin B1 by the rat.
    Gurtoo HL; Motycka L
    Cancer Res; 1976 Dec; 36(12):4663-71. PubMed ID: 1000509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural identification of the major DNA adduct formed by aflatoxin B1 in vitro.
    Essigmann JM; Croy RG; Nadzan AM; Busby WF; Reinhold VN; Büchi G; Wogan GN
    Proc Natl Acad Sci U S A; 1977 May; 74(5):1870-4. PubMed ID: 266709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of phenobarbital and beta-naphthoflavone on the in vivo toxicity and in vitro metabolism of aflatoxin in an aflatoxin-resistant and control line of chickens.
    Manning RO; Wyatt RD; Marks HL
    J Toxicol Environ Health; 1990 Dec; 31(4):291-311. PubMed ID: 2123938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.